Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 38 of 123)
- Relevance
  Sort by

Market Spotlight: Small-Cell Lung Cancer (SCLC)

 Report
November 2020
49 Pages
Global

€1198EUR$1,318USD£1,026GBP

Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Oral Controlled Drug Delivery System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Liver Fibrosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
105 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Cancer Monoclonal Antibodies Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
185 Pages
Global

From

€4090EUR$4,500USD£3,502GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hospital Infection Therapeutics Market Report by Drug Type, Indication, and Region 2024-2032

 Report
August 2024
140 Pages
Global

From

€2726EUR$2,999USD£2,334GBP

Factor XI inhibitors - Pipeline Insight, 2024

 Drug Pipelines
January 2024
60 Pages
Global

From

€1363EUR$1,500USD£1,167GBP

Angiotensin Receptor Blocker Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

 Report
February 2024
111 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Natural Killer Cells Therapeutics Market Report by Therapeutics, Application, End User, and Region 2024-2032

 Report
August 2024
140 Pages
Global

From

€2726EUR$2,999USD£2,334GBP

Systemic Lupus Erythematosus Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
January 2024
150 Pages
Global

From

€4408EUR$4,850USD£3,775GBP

Glomerulonephritis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
89 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Vulvovaginal Candidiasis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Clotrimazole, Fluconazole, Terconazole), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

 Report
November 2022
100 Pages
Global

From

€5408EUR$5,950USD£4,631GBP

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

 Report
August 2023
70 Pages
Latin America

From

€4317EUR$4,750USD£3,697GBP

Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class; Action Mechanism, and Geography

 Report
April 2021
Global

From

€4045EUR$4,450USD£3,463GBP

Antiplatelet Drugs Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4498EUR$4,949USD£3,852GBP

Bartter Syndrome Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
July 2024
77 Pages
Global

From

€3500EUR$4,125USD£3,102GBP

Minimal Change Disease - Pipeline Insight, 2024

 Clinical Trials
April 2024
40 Pages
Global

From

€1136EUR$1,250USD£973GBP

Nephrotic syndrome - Pipeline Insight, 2024

 Drug Pipelines
April 2024
40 Pages
Global

From

€1136EUR$1,250USD£973GBP

Korea Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
80 Pages
South Korea

From

€4317EUR$4,750USD£3,697GBP

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

 Report
October 2023
146 Pages
Global

From

€3206EUR$3,528USD£2,745GBP

€3772EUR$4,150USD£3,230GBP

2,452 Results (Page 38 of 123)
- 1
- 36
- 37
- 38
- 39
- 40

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.